Sept 7 Mylan Inc said it settled with
Pfizer Inc a lawsuit that accused it of infringing
patents on overactive bladder drug Detrol LA.
Mylan can start selling its generic versions of Pfizer's
drug from Jan. 1, 2014, or earlier under some limited
circumstances, but not after March 1, 2014, if the U.S. Food and
Drug Administration approves.
Terms of the settlement are subject to review by the Federal
Trade Commission and the U.S. Department of Justice, and other
details are confidential, Mylan said.
The settlement with Mylan comes days after Pfizer resolved a
similar dispute with Impax Laboratories Inc late last